Literature DB >> 15886907

Quality of life and functional long-term outcome after partial pancreatoduodenectomy: pancreatogastrostomy versus pancreatojejunostomy.

Ursula Schmidt1, Denis Simunec, Pompiliu Piso, Jürgen Klempnauer, Hans J Schlitt.   

Abstract

BACKGROUND: To determine the effects of pancreatogastrostomy (PG) versus pancreatojejunostomy (PJ) as types of reconstruction after partial pancreatoduodenectomy on postoperative quality of life and long-term gastrointestinal morbidity, the outcomes of 104 patients (PG, n = 63; PJ, n = 41) were evaluated.
METHODS: To compare the two groups, the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire (QLQ-PAN 26) standard and an additional self-developed questionnaire were used. The mean time after surgery was 6.4 +/- 3.4 years.
RESULTS: In the PG group, there was a significant reduction of gastric acid reflux, gastroduodenal ulcers, and pain compared with before surgery. However, a significant increase in steatorrhea, intolerance toward larger meals, and aversion against certain foods were observed. In the PJ group, no significant change of preoperative symptoms was present except for jaundice. The incidence of diabetes mellitus and the need for pancreatic enzyme substitution had increased significantly but similarly in both groups. The global quality of life was identical in both groups of patients.
CONCLUSIONS: This analysis demonstrates that the global quality of life was not affected by the type of reconstruction after partial pancreatoduodenectomy. Patients who underwent PG had a significant reduction of gastric reflux, pain, and abdominal discomfort compared with before surgery. Patients in both groups showed an impaired exocrine and endocrine pancreatic function of a similar extent.

Entities:  

Mesh:

Year:  2005        PMID: 15886907     DOI: 10.1245/ASO.2005.04.005

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  Correlation of clinical stage and performance status with quality of life in patients seen in a pancreas multidisciplinary clinic.

Authors:  Shalini Moningi; Amanda J Walker; Charles C Hsu; Jennifer Barsky Reese; Jing-Ya Wang; Katherine Y Fan; Lauren M Rosati; Daniel A Laheru; Matthew J Weiss; Christopher L Wolfgang; Timothy M Pawlik; Joseph M Herman
Journal:  J Oncol Pract       Date:  2015-01-06       Impact factor: 3.840

Review 2.  Pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Michael Clerveus; Antonio Morandeira-Rivas; Joaquín Picazo-Yeste; Carlos Moreno-Sanz
Journal:  J Gastrointest Surg       Date:  2014-06-06       Impact factor: 3.452

3.  Symptomatic change and gastrointestinal quality of life after pancreatectomy.

Authors:  Lewis Rashid; Vic Velanovich
Journal:  HPB (Oxford)       Date:  2011-10-25       Impact factor: 3.647

Review 4.  Is antisecretory therapy after pancreatoduodenectomy necessary? Meta-analysis and contemporary practices of pancreatic surgeons.

Authors:  James R Butler; Tyrone Rogers; George Eckart; Gregory R Martens; Eugene P Ceppa; Michael G House; Attila Nakeeb; C Max Schmidt; Nicholas J Zyromski
Journal:  J Gastrointest Surg       Date:  2015-02-18       Impact factor: 3.452

5.  Pancreatic exocrine insufficiency after pancreaticoduodenectomy is more prevalent with pancreaticogastrostomy than with pancreaticojejunostomy. A retrospective multicentre observational cohort study.

Authors:  Geert Roeyen; Miet Jansen; Laure Ruyssinck; Thiery Chapelle; Aude Vanlander; Bart Bracke; Vera Hartman; Dirk Ysebaert; Frederik Berrevoet
Journal:  HPB (Oxford)       Date:  2016-10-07       Impact factor: 3.647

6.  Which method should we select for pancreatic anastomosis after pancreaticoduodenectomy?

Authors:  Ji Hun Kim; Byung Moo Yoo; Jin Hong Kim; Wook Hwan Kim
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

7.  Comparative long-term outcomes for pancreatic volume change, nutritional status, and incidence of new-onset diabetes between pancreatogastrostomy and pancreatojejunostomy after pancreaticoduodenectomy.

Authors:  Bong Jun Kwak; Ho Joong Choi; Young Kyoung You; Dong Goo Kim; Tae Ho Hong
Journal:  Hepatobiliary Surg Nutr       Date:  2020-06       Impact factor: 7.293

8.  Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial.

Authors:  Tobias Keck; U F Wellner; M Bahra; F Klein; O Sick; M Niedergethmann; T J Wilhelm; S A Farkas; T Börner; C Bruns; A Kleespies; J Kleeff; A L Mihaljevic; W Uhl; A Chromik; V Fendrich; K Heeger; W Padberg; A Hecker; U P Neumann; K Junge; J C Kalff; T R Glowka; J Werner; P Knebel; P Piso; M Mayr; J Izbicki; Y Vashist; P Bronsert; T Bruckner; R Limprecht; M K Diener; I Rossion; I Wegener; U T Hopt
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

Review 9.  Pancreatic outflow tract reconstruction after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.

Authors:  Xin Xin Wang; Yu Ke Yan; Bao Long Dong; Yuan Li; Xiao Jun Yang
Journal:  World J Surg Oncol       Date:  2021-07-06       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.